Eric Honroth, newly appointed President and CEO of AngioDynamics Inc, filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities beneficially owned as of the event date of November 2, 2026.

Key Highlights

  • Reporting person: Eric Honroth, identified in the filing as President and CEO and Director of AngioDynamics Inc (NASDAQ:ANGO).
  • Event date: The date of the event requiring the statement is listed as November 2, 2026.
  • Filing date: The form was signed and filed on November 4, 2026.
  • No securities held: The filing states "No securities are beneficially owned" in both Table I (non-derivative securities) and Table II (derivative securities).
  • Filing type: This is an initial statement, not an amendment, filed by one reporting person.
  • Power of attorney: Exhibit 24.1, a Power of Attorney, is listed as part of the filing.

Honroth Reports Zero Beneficial Ownership at AngioDynamics Appointment

According to the filing, Eric Honroth submitted a Form 3 Initial Statement of Beneficial Ownership of Securities in connection with his role at AngioDynamics Inc, ticker NASDAQ:ANGO, with an event date of November 2, 2026. The filing identifies Honroth as both a Director and an Officer, with the specific title of President and CEO. His address on record is 14 Plaza Drive, Latham, New York 12110.

The filing discloses no beneficially owned securities of any kind. Table I, covering non-derivative securities, contains no entries. Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, also contains no entries. The remarks section of the form explicitly states, "No securities are beneficially owned." The form was filed by one reporting person and is not an amendment to any prior filing.

The filing was signed by Eric Honroth on November 4, 2026. An Exhibit 24.1, described as a Power of Attorney, is included in the exhibit list accompanying the submission.

What Was Disclosed

Eric Honroth, President and CEO and Director of AngioDynamics Inc (NASDAQ:ANGO), filed an initial beneficial ownership statement dated November 4, 2026, reporting no direct or indirect holdings in any non-derivative or derivative securities of the company as of November 2, 2026.